NCT00097929 2017-04-07An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)Merck Sharp & Dohme LLCPhase 2 Completed18 enrolled
NCT00091559 2017-04-05Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)Merck Sharp & Dohme LLCPhase 2 Completed74 enrolled